List of Tables
Table 1. Global IL-4Rα Targeting Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global IL-4Rα Targeting Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global IL-4Rα Targeting Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global IL-4Rα Targeting Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global IL-4Rα Targeting Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global IL-4Rα Targeting Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market IL-4Rα Targeting Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of IL-4Rα Targeting Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of IL-4Rα Targeting Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of IL-4Rα Targeting Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of IL-4Rα Targeting Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IL-4Rα Targeting Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on IL-4Rα Targeting Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IL-4Rα Targeting Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global IL-4Rα Targeting Drugs Sales by Region (K Units), 2021–2026
Table 18. Global IL-4Rα Targeting Drugs Sales Market Share by Region (2021–2026)
Table 19. Global IL-4Rα Targeting Drugs Sales by Region (K Units), 2027–2032
Table 20. Global IL-4Rα Targeting Drugs Sales Market Share by Region (2027–2032)
Table 21. Global IL-4Rα Targeting Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global IL-4Rα Targeting Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global IL-4Rα Targeting Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global IL-4Rα Targeting Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America IL-4Rα Targeting Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America IL-4Rα Targeting Drugs Sales by Country (K Units), 2021–2026
Table 27. North America IL-4Rα Targeting Drugs Sales by Country (K Units), 2027–2032
Table 28. North America IL-4Rα Targeting Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America IL-4Rα Targeting Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe IL-4Rα Targeting Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe IL-4Rα Targeting Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe IL-4Rα Targeting Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe IL-4Rα Targeting Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe IL-4Rα Targeting Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific IL-4Rα Targeting Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific IL-4Rα Targeting Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific IL-4Rα Targeting Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific IL-4Rα Targeting Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific IL-4Rα Targeting Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America IL-4Rα Targeting Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America IL-4Rα Targeting Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America IL-4Rα Targeting Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America IL-4Rα Targeting Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America IL-4Rα Targeting Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa IL-4Rα Targeting Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa IL-4Rα Targeting Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa IL-4Rα Targeting Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa IL-4Rα Targeting Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa IL-4Rα Targeting Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global IL-4Rα Targeting Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global IL-4Rα Targeting Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global IL-4Rα Targeting Drugs Sales Market Share by Type (2021–2026)
Table 53. Global IL-4Rα Targeting Drugs Sales Market Share by Type (2027–2032)
Table 54. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global IL-4Rα Targeting Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global IL-4Rα Targeting Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global IL-4Rα Targeting Drugs Sales Market Share by Application (2021–2026)
Table 63. Global IL-4Rα Targeting Drugs Sales Market Share by Application (2027–2032)
Table 64. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Regeneron Company Information
Table 71. Regeneron Description and Business Overview
Table 72. Regeneron IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Regeneron IL-4Rα Targeting Drugs Product
Table 74. Regeneron Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Sanofi IL-4Rα Targeting Drugs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Sunshine Guojian Company Information
Table 81. Sunshine Guojian Description and Business Overview
Table 82. Sunshine Guojian IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Sunshine Guojian IL-4Rα Targeting Drugs Product
Table 84. Sunshine Guojian Recent Developments/Updates
Table 85. Qingzhixiang Jintai Biopharmaceuticals Company Information
Table 86. Qingzhixiang Jintai Biopharmaceuticals Description and Business Overview
Table 87. Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Product
Table 89. Qingzhixiang Jintai Biopharmaceuticals Recent Developments/Updates
Table 90. Conoya Biopharmaceuticals Company Information
Table 91. Conoya Biopharmaceuticals Description and Business Overview
Table 92. Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Product
Table 94. Conoya Biopharmaceuticals Recent Developments/Updates
Table 95. Connaide Biopharmaceuticals Company Information
Table 96. Connaide Biopharmaceuticals Description and Business Overview
Table 97. Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Product
Table 99. Connaide Biopharmaceuticals Recent Developments/Updates
Table 100. Kengfang Biopharmaceuticals Company Information
Table 101. Kengfang Biopharmaceuticals Description and Business Overview
Table 102. Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Product
Table 104. Kengfang Biopharmaceuticals Recent Developments/Updates
Table 105. Hengrui Medical Company Information
Table 106. Hengrui Medical Description and Business Overview
Table 107. Hengrui Medical IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Hengrui Medical IL-4Rα Targeting Drugs Product
Table 109. Hengrui Medical Recent Developments/Updates
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. AstraZeneca IL-4Rα Targeting Drugs Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Innovent Biologics Company Information
Table 116. Innovent Biologics Description and Business Overview
Table 117. Innovent Biologics IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Innovent Biologics IL-4Rα Targeting Drugs Product
Table 119. Innovent Biologics Recent Developments/Updates
Table 120. Numab Therapeutics Company Information
Table 121. Numab Therapeutics Description and Business Overview
Table 122. Numab Therapeutics IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Numab Therapeutics IL-4Rα Targeting Drugs Product
Table 124. Numab Therapeutics Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. IL-4Rα Targeting Drugs Distributors List
Table 128. IL-4Rα Targeting Drugs Customers List
Table 129. IL-4Rα Targeting Drugs Market Trends
Table 130. IL-4Rα Targeting Drugs Market Drivers
Table 131. IL-4Rα Targeting Drugs Market Challenges
Table 132. IL-4Rα Targeting Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of IL-4Rα Targeting Drugs
Figure 2. Global IL-4Rα Targeting Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global IL-4Rα Targeting Drugs Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Fusion Proteins Product Picture
Figure 6. Small Molecule Inhibitors Product Picture
Figure 7. Vaccines Product Picture
Figure 8. Global IL-4Rα Targeting Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global IL-4Rα Targeting Drugs Market Share by Application: 2025 & 2032
Figure 10. Atopic Dermatitis
Figure 11. Asthma
Figure 12. Chronic Sinusitis with Nasal Polyps
Figure 13. Other
Figure 14. Global IL-4Rα Targeting Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global IL-4Rα Targeting Drugs Market Size (US$ Million), 2021–2032
Figure 16. Global IL-4Rα Targeting Drugs Sales (K Units), 2021–2032
Figure 17. Global IL-4Rα Targeting Drugs Average Price (US$/Unit), 2021–2032
Figure 18. IL-4Rα Targeting Drugs Report Years Considered
Figure 19. IL-4Rα Targeting Drugs Sales Share by Manufacturers in 2025
Figure 20. Global IL-4Rα Targeting Drugs Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global IL-4Rα Targeting Drugs Players: Market Share by Revenue in IL-4Rα Targeting Drugs in 2025
Figure 22. IL-4Rα Targeting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global IL-4Rα Targeting Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America IL-4Rα Targeting Drugs Sales Market Share by Country (2021–2032)
Figure 25. North America IL-4Rα Targeting Drugs Revenue Market Share by Country (2021–2032)
Figure 26. United States IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe IL-4Rα Targeting Drugs Sales Market Share by Country (2021–2032)
Figure 29. Europe IL-4Rα Targeting Drugs Revenue Market Share by Country (2021–2032)
Figure 30. Germany IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific IL-4Rα Targeting Drugs Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific IL-4Rα Targeting Drugs Revenue Market Share by Region (2021–2032)
Figure 37. China IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America IL-4Rα Targeting Drugs Sales Market Share by Country (2021–2032)
Figure 45. Latin America IL-4Rα Targeting Drugs Revenue Market Share by Country (2021–2032)
Figure 46. Mexico IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa IL-4Rα Targeting Drugs Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa IL-4Rα Targeting Drugs Revenue Market Share by Country (2021–2032)
Figure 52. Turkey IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE IL-4Rα Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of IL-4Rα Targeting Drugs by Type (2021–2032)
Figure 56. Global Revenue Market Share of IL-4Rα Targeting Drugs by Type (2021–2032)
Figure 57. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of IL-4Rα Targeting Drugs by Application (2021–2032)
Figure 59. Global Revenue Market Share of IL-4Rα Targeting Drugs by Application (2021–2032)
Figure 60. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Application (2021–2032)
Figure 61. IL-4Rα Targeting Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
